ESPAÑOL
Home
Mission & objectives
Partners and allies
R&D division
Generics Division
Professionals
Investors
Vademecum
Contact
Links of interest
News and notes of interest
Press Release
LA PROVINCIA
-
"Ceamed obtained the licence to produce natural antitumor generics"
also available
newspaper cover
(20/07/10)
CEAMED gets approval of its first generic drug record by the Spanish Agency of Drugs and Health Products (AEMPS), Ministry of Health and Social Welfare.
The Ibuprofen CEAMED starts up the Vademecum of the firm (26th February 2010)
CEAMED and FICIC, founders of the Cluster Biotechnology and Pharmaceutical Industry of Canary Islands. Tenerife Scientific and Technological Park (PCTT) announces that both will go to Mesa Mota
(18/01/10)
CEAMED S.A. has applied for a Pharmaceutical Laboratory licence to the Ministry of Health and Consumer (9th Dec. 2009)
Press Release
CANARIAS 7
-
Sales of Generic Drugs finance cancer research. CEAMED SA and FICIC work on new drugs
(7/12/09)
CEAMED S.A. has been admitted as the first Biotechnology Company of the Tenerife Scientific and Technological Park (30th April 2009).
CEAMED S.A. registered its antitumor Fenbunafide patent. This is a DNA intercalant and topoisomerase-II inhibitor (3rd May 2007).
El Dia. The University of La Laguna (ULL) will commercially exploit its research results
(30/11/07)
HPV 3D Video